Scientists sweep
cellular neighborhoods
where Zika hides out

Interrogating the virus’ molecular associates
yields clues about where to apply pressure

Published October 01 2018

This space-fill drawing shows the outside of one Zika virus particle and a cross-section through another as it interacts with a cell. The two main proteins of the viral envelope, the envelope and membrane proteins, are red and purple, respectively. The lipid membrane of the envelope is light lavender. The capsid proteins, in orange, interact with the RNA genome, in yellow, at the center of the virus. The cell-surface receptor proteins are green, the cytoskeleton is blue and blood plasma proteins are gold. Courtesy of David Goodsell/Wikimedia Commons Most people infected with Zika never show symptoms. But the virus sometimes causes severe disability — from microcephaly in babies to weakness or partial paralysis in adults — and there is no treatment. In a paper in the journal Molecular & Cellular Proteomics, researchers report a comprehensive study of how the virus interacts with host cells. One of their findings gives insight into how Zika escapes immune signaling and proliferates inside the body.

Like most viruses, Zika accomplishes a lot with a few tools. It has just one protein coding gene, which produces a single polypeptide that’s cleaved into 10 smaller proteins — a number dwarfed by the estimated 20,000 protein-coding genes in a human cell. Nevertheless, Zika can take over the vastly more complex human cell, repurposing it into a virus factory. Brian Raught, a researcher at the University of Toronto, said he found that process fascinating.

“With just these 10 proteins, this crazy virus turns your cells into zombies that do its bidding,” Raught said. “I always found that mind-blowing.”

Researchers in Raught’s lab, led by postdoctoral fellow Etienne Coyaud, wanted to find out how the handful of Zika proteins were able to hijack the host cell. They knew that the feat must depend on physical interactions between viral proteins and proteins native to the cell — but which ones?

Because of the increasing evidence linking Zika infections in expectant mothers to microcephaly in their children, Raught said, “We thought it better to leave the actual virus work to the experts.”

Instead of using infectious material, the team made 10 strains of human cells, each expressing one of Zika’s 10 proteins. By adding a small epitope tag to each viral protein, they were able to retrieve the viral proteins using an antibody that binds to this tag. The host proteins that stuck tightly to each viral protein came along for the ride; the researchers used mass spectrometry to identify those human proteins.

But there was a drawback to using this approach. What if proteins from the human cell were interacting with Zika proteins but separating from them before being extracted? To identify proteins that are close to but not inseparably intertwined with each viral protein, the team used a second technique called proximity labeling. In essence, they rigged each viral protein with an enzyme that would attach a sticky biotin tag onto anything that came close enough.

Proximity labeling is especially useful for detecting interactions with proteins embedded in cell membranes; those molecules are notoriously difficult to isolate.

“This is a really big asset of a proximity-labeling approach compared to traditional approaches,” Coyaud said.

Because Zika, like many viruses, enters the cell in a membrane-bound envelope and reorganizes many of its host’s membrane-bound organelles in the course of infection, its interactions with membrane proteins might be key to understanding the viral life cycle.

Related articles

Crazy for Cryo-EM
This technique was used to figure out the structure of Zika virus by two groups concurrently in 2016. Find out how in this feature by Raj Mukhopadyay.

What makes organelles connect?
Interested in what else we can learn from proximity labeling proteomics? A recent study published in JBC, covered by Sasha Mushegian, used a similar technique to probe healthy cells.

Also by this author

Collaboration, born at a poster session

Finding the structure of a lipid that keeps our tears clear

Real-time proteomics may one day speed cancer surgery

When the researchers combined the results of the two approaches, they could piece together a detailed picture of what Raught calls the “neighborhood” within the cell where each Zika protein takes up residence.

For example, the researchers found that one Zika protein, called NS2A, interacted with many human neighbors in a host organelle called the peroxisome. Peroxisomes are involved in innate immune signaling, a type of early-warning alarm that goes off when viruses are present. Proteins from dengue and West Nile viruses, which are in the same family as Zika, have been shown to associate with peroxisomes and disrupt antiviral signaling.

Using fluorescence microscopy, Raught said, “we could see that this one protein (NS2A) only localized to peroxisomes.”

Because NS2A is thought to be involved in replication of the virus’ genome and construction of its protein shell, its preference for the peroxisome led the team to investigate whether the peroxisome might be involved in replication. The team recruited some virologists with access to a biocontainment facility who could test whether infectious Zika virus can proliferate in cells without peroxisomes. Turns out, in those cells, the virus proliferates more slowly.

“There really does appear to be an important link between having a peroxisome and being able to efficiently make Zika virus,” Raught said. “We don’t know exactly why that is.” But the host-virus protein interaction data showed them where to look.

The data set Raught’s lab has collected is full of such clues. Slightly more than half of the human proteins the researchers found interacting with viral proteins are known to be involved in other viral infections, while the rest had not yet been described.

According to Raught, “A better understanding of these processes will allow us to identify specific vulnerabilities in the virus life cycle, where antiviral drugs can be targeted.”

Laurel Oldach Laurel Oldach is a science communicator for the Journal of Lipid Research and Molecular & Cellular Proteomics and a science writer for ASBMB Today. Follow her on Twitter.